Tag: FDA Inspection Observations

If you don’t find what you are looking for, try using a different term or contact us.

Featured image for GMP Insiders article on FDA draft guidance for responding to Form 483 observations, showing a hand stamping a document beside a laptop.

FDA Draft Guidance on Responding to Form 483 Observations

FDA’s draft guidance on Form 483 responses outlines what drug manufacturers should do on timing, investigation, risk assessment, and effective...
FY 2025 FDA inspection observations visual – quality audit and compliance review with executive hands analyzing reports and regulatory data.

FY 2025 FDA Inspection Observations: Quality Maturity in Drug and Medical Device Manufacturing

FY 2025 FDA inspection observations reveal recurring weaknesses in drug and medical device manufacturing, highlighting quality maturity, governance, and lifecycle...

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News!